2137.HK · BRII-B
Hong Kong · RS rating 13 · As of 2026-10-14
| Price | 0.83 HKD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 41 / 19 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 2 / 14 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +63.9% |
| Market cap (USD) | $79.1M |